Photon-Counting CT Improves Tumor Detection

Lower-dose scans were associated with improved tumor feature detection and fewer adverse events compared with standard imaging

By
Andrea Surnit
April 24, 2026
3 min

Conexiant

Objective:

To evaluate the effectiveness of photon-counting computed tomography (PCCT) in detecting malignant features in lung cancer patients compared to standard energy-integrating detector computed tomography (EID CT) in a diverse patient population.

Key Findings:

PCCT detected more malignant imaging features (291 to 340) compared to EID CT (194 to 255), with subgroup analyses indicating improved detection in smaller tumors.
Diagnostic confidence scores were higher with PCCT.
Overall image quality was superior with PCCT, especially for enhanced lesions.
Radiation exposure decreased by 66% (1.36 mSv vs 4.04 mSv) with PCCT.
Iodine load decreased by 27% with PCCT.
Adverse reactions occurred in 2% of PCCT patients vs 9% with EID CT.
Contrast-induced acute kidney injury occurred in 1% of PCCT patients vs 7% with EID CT.

Interpretation:

PCCT significantly enhances tumor detection and diagnostic confidence while minimizing radiation and contrast exposure risks in lung cancer patients.

Limitations:

Single-center design may limit generalizability, particularly outside of the Chinese population.
Imaging parameters differed between groups, which may affect the results.
Some subgroup analyses were conducted post hoc, which could introduce bias.

Conclusion:

PCCT improves overall image quality, detection of malignant features, and diagnostic confidence in lung cancer imaging while significantly reducing radiation and contrast exposure risks.